SCHEMBL27656527

SCHEMBL27656527

NC(=O)c1ccccc1-c1ccc(-c2ccccc2Cl)cc1C(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 1/20 0.51
▸ PDK2 Q15119 2/20 0.46
▸ DHODH Q02127 1/20 0.46
▸ RORB Q92753 4/20 0.45
▸ RORC P51449 4/20 0.45
▸ IKBKB O14920 1/20 0.44
▸ BCAT2 O15382 1/20 0.43
▸ CHEK1 O14757 1/20 0.42
▸ ALOX5AP P20292 1/20 0.42
▸ FEN1 P39748 1/20 0.42
▸ EIF4E P06730 1/20 0.42
▸ SCN9A Q15858 2/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ AKR1C3 P42330 1/20 0.41
▸ AKR1C2 P52895 1/20 0.41
▸ TACR1 P25103 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27635470 0.82 BCAT2 (0.63) PDK2RORBRORCIKBKBBCAT2
SCHEMBL28856804 0.79 BCAT2 (0.45) PDK2BCAT2ALOX5APFEN1EIF4E
SCHEMBL27656528 0.79 BCAT2 (0.54) PDK2RORBRORCIKBKBBCAT2
SCHEMBL5143960 0.78 PARP1 (0.56) PDK2BCAT2SCN9AAKR1C3AKR1C2
SCHEMBL30608075 0.78 PARP1 (0.56) PDK2BCAT2SCN9AAKR1C3AKR1C2
SCHEMBL31583298 0.78 BCAT2 (0.51) PDK2RORBRORCBCAT2CHEK1
SCHEMBL5131379 0.78 PDK2 (0.49) PDK2RORCMAPK14AKR1C3AKR1C2
SCHEMBL27925864 0.77 IKBKB (0.52) PDK2IKBKBBCAT2CHEK1SCN9A
SCHEMBL6187171 0.77 BCAT2 (0.50) PDK2RORBRORCBCAT2CHEK1
SCHEMBL1203519 0.76 BCAT2 (0.59) IKBKBBCAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102793692-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP 2012-11-28 — — CN claimed
CN-1826120-A Compounds for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP (US) 2006-08-30 — — CN claimed
Send feedback